BAI Announces 2021 Global Innovation Award Finalists
BAI announced the finalists for the 11th Annual 2021 BAI Global Innovation Awards, the industry’s prestigious awards program that celebrates new and innovative solutions in the financial services industry worldwide. The 2021 BAI Global Innovation Awards finalists are:
Innovation in Compliance and Risk Management
- Emirates NBD Bank, United Arab Emirates: Transforming the Anti-Money Laundering Framework
- Hummingbird, United States: Hummingbird Platform
- UnionBank of the Philippines, Philippines: Credit Card Fraud Detection Model
Innovation in Consumer Product and Services
- Commonwealth Bank of Australia, Australia: CommBank Benefits Finder
- FNB Insurance, South Africa: Future Family Benefit on Critical Illness
- ICICI Bank, India: IntelliCollect – AI powered Contactless Collection
- PNC Financial Services Group, United States: Low Cash Mode
- Yapı Kredi, Turkey: My Car+: Everything about your vehicle
Innovation in Digital Transformation
- AVIVA POLSKA, Poland: eInsurance Digital Omnichannel Life Insurance Application Journey
- Bank of America, United States: Bank of America Mobile Banking Super App
- Deutsche Bank, Germany: Deutsche Bank API Program Embedded Finance Initiative
- OneConnect Smart Technology Co., LTD, China: Global Markets Digital Lab in Abu Dhabi
- SolarisBank, Netherlands: Banking as a Service
Innovation in Human Capital
- KeyBank, United States: Remote Intern Program
- Payactiv, United States: Livelihood Employee Experience Platform
- Royal Credit Union, United States: Employee Learning Experience
Innovation in Environmental, Social and Governance (ESG)
- Bank of Montreal, Canada: BMO Give & Go
- BMO Harris Bank, United States: BMO for Black and Latinx Businesses
- Citizens Financial Group, United States: Citizens Green Deposits
- imagin, Spain: imagin: A Community with a Positive Impact
- Lufax Holding Ltd., China: Farmers’ Assistance Fund
- Wintrust Financial Corporation, United States: Wintrust Paycheck Protection Program (PPP) Resource Centers
Innovation in Internal Process
- Alior Bank, Poland: InfoNina, virtual assistant
- ICICI Bank, India: Pre-Delinquency Management
- Israel Discount Bank, Israel: POPCORN - An Innovative Customer Listening Model
- PKO Bank Polski, Poland: Road to Paperless Banking Empowered by Blockchain Technology
- PZU SA, South Africa: AI Assistant in Claims (Field Inspection)
Innovation in Small Business Product & Services
- HSBC UK, United Kingdom: HSBC Kinetic, Mobile Banking Service
- Lufax Holding Ltd., China: Lufax "Xingyun" Smart Loan Solution
- Ping An OneConnect Bank Limited, Hong Kong: “PAOB SME" Mobile Application
- Santander Bank, N.A., United States: Santander Treasury Fusion for Where You Do Business
- Tribal Credit, United States: Tribal Credit Tools
The winners will be announced in December 2021. To learn more please visit BAI Global Innovation Awards.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211109005488/en/
Contact information
Holly Hughes
BAI, Chicago
hhughes@bai.org
+1 (312) 683-2305
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking7.1.2026 15:00:00 EET | Press release
Prudentia Sciences, a pioneer in AI-native due diligence for life sciences dealmaking, today announced that it has secured $20 million in Series A financing. The round was led by McKesson Ventures with participation from SignalFire. Existing investors include Iaso Ventures, Virtue and GV. This brings the company’s total funding to $27 million, following a $7 million seed round in 2024. Prudentia Sciences provides an AI-native platform that enables pharma companies, biotechs, and financial institutions to evaluate breakthrough medicines with unprecedented speed and rigor. By synthesizing complex clinical signals into actionable insights, Prudentia accelerates deal throughput and provides strategic leverage for acquisition, licensing, or investment decisions made by business development, investment, and diligence teams. The company’s human-in-the-loop approach orchestrates seamless collaboration between buyers, sellers, and intermediaries. This ensures a secure, compliant infrastructure
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD7.1.2026 13:30:00 EET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for COMP360, enabling the initiation of a late-stage clinical trial in patients with PTSD. Compass management, along with KOL and industry leaders, will host a webinar today to discuss the company’s clinical trial plans for PTSD, as well as commercial preparations for treatment-resistant depression (TRD) from 10:00-11:30 am ET on January 7th. “PTSD is one of the most challenging mental health conditions, with approximately 13 million adults in the U.S. living with persistent symptoms and limited treatment options,” said Dr. Guy Goodwin, Chief Medical Officer at Compass Pathways. “We are pleased to advance our clinical development - the unmet need is profound, and it demands bold innovation. We believe COMP360 has the potential to tra
Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.7.1.2026 12:07:00 EET | Press release
Stallergenes Greer, a global leader in allergy therapeutics, today announced that it has entered into an agreement to acquire Entomon s.r.l., an Italian company specialising in the production of certified stinging-insect venom extracts, notably of the Hymenoptera order, used for the manufacture of diagnostic preparations and Venom Immunotherapy (VIT). The transaction is expected to close by the end of January. Entomon, currently recognised as the only company in Europe capable of extracting pure venom from Hymenoptera insects, produces pharmaceutical-grade insect venom using proprietary techniques (Entomon Capillary Extracted Venom®) for medical use. Through this acquisition, Stallergenes Greer bolsters its venom manufacturing capabilities and supply of raw materials for life-saving VIT treatments, whilst safeguarding patient care continuity. Hymenoptera venom allergy is the most common trigger of severe anaphylaxis in adults1. According to the EAACI guidelines on venom immunotherapy,
ARIS Announces New CEO to Lead Agentic AI-led Strategy7.1.2026 11:00:00 EET | Press release
CEO Appointment ARIS, a global leader in process intelligence and transformation software, today announced the appointment of Guillaume Bacuvier as Chief Executive Officer. Guillaume will lead ARIS through its next phase of growth as a fully standalone company, accelerating its evolution from a market leader in Process Intelligence into a foundational platform for enterprises deploying and governing Agentic AI. Guillaume brings deep international leadership experience across technology, data, and software-enabled businesses, with a proven track record of scaling global platforms and leading complex organisations. After starting as a strategic consultant at Booz Allen Hamilton, Guillaume spent over a decade at Google, rising to Vice President in EMEA where he built and scaled some of Google’s largest data-driven businesses in Europe and held P&L responsibility across multiple countries. In the last decade, Guillaume has served as CEO of multi-continent, data-centric companies including
I Squared Capital Acquires Ramudden Global, a Leader in Traffic Management and Infrastructure Safety7.1.2026 10:00:00 EET | Press release
I Squared Capital, a leading global infrastructure investment manager, today announced that, through its flagship fund, it has agreed to acquire Ramudden Global, from funds advised by Triton Partners (“Triton”), a leading European mid-market sector-specialist investor. Ramudden Global is a leading international provider of traffic management and infrastructure safety services supporting the maintenance and upgrade of essential transport and utility networks. The company operates more than 190 depots across 13 countries in Europe and North America delivering mission-critical services that help to ensure safety, regulatory compliance and continuity of service across road, utility and broader infrastructure works. This investment underscores I Squared Capital’s commitment to investing in essential, regulated, infrastructure businesses that underpin public safety, mobility and economic activity. Ramudden operates in markets where demand is steady and growing and benefits from deep commerci
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom